請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/24166完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 柯逢春 | |
| dc.contributor.author | Kai－hsiung Chang | en |
| dc.contributor.author | 張凱雄 | zh_TW |
| dc.date.accessioned | 2021-06-08T05:17:28Z | - |
| dc.date.issued | 2004 | |
| dc.identifier.citation | Ashcroft, M., Ludwig, R. L., Woods, D. B., Copeland, T. D., Weber, H.O., MacRae, E. J., and Vousden, K. H. (2002). Phosphorylation of HDM2 by Akt. Oncogene2l, 1955-1962.
Blackburn, E. H. (2000). Telomere states and cell fates. Nature 408,53-56. Boddy, M. N., Freemont, P. S., and Borden, K. L. (1994). The p53-associated protein HDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem Sci 19,198-199. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352. Broccoli, D., Chong, L., Oelmann, S., Fernald, A. A., Marziliano, N., van Steensel, B., Kipling, D., Le Beau, M. M., and de Lange, T. (1997). Comparison of the human and mouse genes encoding the telomeric protein, TRF1: chromosomal localization, expression and conserved protein domains. Hum Mol Genet 6, 69-76. Buschmann, T., Lerner, D., Lee, C. G, and Ronai, Z. (2001). The Mdm-2 amino terminus is required for Mdm2 binding and SUMO- 1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J Biol Chem 276,40389-40395. Chen, L., and Chen, J. (2003). HDM2-ARF complex regulates p53 sumoylation. Oncogene 22, 5348-5357. Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., and de Lange, T. (1995). A human telomeric protein. Science 270, 1663-1667. Dalton, T. P., Shertzer, H. G., and Puga, A. (1999). Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39, 67-101. Desterro, J. M., Rodriguez, M. S., and Hay, R. T. (1998). SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2, 233-239. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G, Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., and et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-9367. Elenbaas, B., Dobbelstein, M., Roth, J., Shenk, T., and Levine, A. J. (1996). The HDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol Med 2, 439-451. Evans, S. C., Viswanathan, M., Grier, J. D., Narayana, M., El-Naggar, A. K., and Lozano, G. (2001). An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2. Oncogene 20, 404 1-4049. Fakharzadeh, S. S., Trusko, S. P., and George, D. L. (1991). Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. Embo J 10, 1565-1569. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., and Weissman, A. M. (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275, 8945-8951. Finkel, T. (2003). Oxidant signals and oxidative stress. Curr Opin Cell Biol 15, 247-254. Goldberg, Z., Vogt Sionov, R., Berger, M., Zwang, Y., Perets, R., Van Etten, R. A., Oren, M., Taya, Y., and Haupt, Y. (2002). Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. Embo J 21, 3715-3727. Greider, C. W. (1996). Telomere length regulation. Annu Rev Biochem 65, 337-365. Greider, C. W. (1999). Telomeres do D-loop-T-loop. Cell 97, 419-422. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. (1999). Mammalian telomeres end in a large duplex loop. Cell 97, 503-514. Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z. X., Kumar, S., Howley, P. M., and Livingston, D. M. (1998). p300/HDM2 complexes participate in HDM2-mediated p53 degradation. Mol Cell 2, 405-415. Guerra, B., and Issinger, O. G. (1998). p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment. FEBS Lett 434, 115-120. Harley, C. B., Futcher, A. B., and Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460. Harman, D. (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol 11, 298-300. Harman, D. (1988). Free radicals in aging. Mol Cell Biochem 84,155-161. Hayflick, L. (1965). The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 37, 6 14-636. Hjerrild, M., Milne, D., Dumaz, N., Hay, T., Issinger, O. G., and Meek, D. (2001). Phosphorylation of murine double minute clone 2 (HDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells. Biochem J 355, 347-356. Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein HDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420, 25-27. Honda, R., and Yasuda, H. (1999). Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. Embo J 18, 22-27. Honda, R., and Yasuda, H. (2000). Activity of HDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19, 1473-1476. Hsieh, J. K., Chan, F. S., O’Connor, D. J., Mittnacht, S., Zhong, S., and Lu, X. (1999). RB regulates the stability and the apoptotic function of p53 via HDM2. Mol Cell 3, 181-193. Hsu, H. L., Gilley, D., Galande, S. A., Hande, M. P., Allen, B., Kim, S. H., Li, G. C., Campisi, J., Kohwi-Shigematsu, T., and Chen, D. J. (2000). Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 14, 2807-28 12. Huang, T. T., Carlson, E. J., Gillespie, A. M., Shi, Y., and Epstein, C. J. (2000). Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Biol Sci Med Sci 55, B5-9. Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y., and Shkedy, D. (1999). Rapid ATM-dependent phosphorylation of HDM2 precedes p53 accumulation in response to DNA damage. Proc Natl. Acad Sci U S A 96, 14973 -14977. Langley, E., Pearson, M., Faretta, M., Bauer, U. M., Frye, R. A., Minucci, S., Pelicci, P. G, and Kouzarides, T. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. Embo J 21,2383-2396. Lin, H. K., Wang, L., Hu, Y. C., Altuwaijri, S., and Chang, C. (2002). Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. Embo J 21, 4037-4048. Lohrum, M. A., Ashcroft, M., Kubbutat, M. H., and Vousden, K. H. (2000). Identification of a cryptic nucleolar-localization signal in HDM2. Nat Cell Biol 2, 179-181. Lohrum, M. A., Ludwig, R. L., Kubbutat, M. H., Hanlon, M., and Vousden, K. H. (2003). Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3, 577-587. Mancini, F., Gentiletti, F., D’Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., and Moretti, F. (2003). MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J Biol Chem 1, 1. Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., and Kufe, D. (2000). Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 275, 21793-21796. Marchenko, N. D., Zaika, A., and Moll, U. M. (2000). Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275, 16202-16212. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J. C., and Levine, A. J. (1994). The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol 14, 7414-7420. Mathon, N. F., and Lloyd, A. C. (2001). Cell senescence and cancer. Nat Rev Cancer 1, 203-213. Mancini, F., Gentiletti, F., D’Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., and Moretti, F. (2003). MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J Biol Chem 1, 1. McEachern, M. J., Krauskopf, A., and Blackburn, E. H. (2000). Telomeres and their control. Annu Rev Genet 34, 331-358. Melov, S., Ravenscroft, J., Malik, S., Gill, M. S., Walker, D. W., Clayton, P. E., Wallace, D. C., Malfroy, B., Doctrow, S. R., and Lithgow, G. J. (2000). Extension of life-span with superoxide dismutase/catalase mimetics. Science 289, 1567-1569. Meng, T. C., Fukada, T., and Tonks, N. K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9,387-399. Momand, J., Zambetti, El P., Olson, D. C., George, D., and Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 123 7-1245. Narita, M., Nunez, S., Heard, E., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., and Lowe, S. W. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716. Nugent, C. I., and Lundblad, V. (1998). The telomerase reverse transcriptase: components and regulation. Genes Dev 12, 1073-1085. Okamoto, K., Li, H., Jensen, M. R., Zhang, T., Taya, Y., Thorgeirsson, S. S., and Prives, C. (2002). Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell 9, 761-771. Olson, D. C., Marechal, V., Momand, J., Chen, J., Romocki, C., and Levine, A. J. (1993). Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8,2353-2360. Parkes, T. L., Elia, A. J., Dickinson, D., Hilliker, A. J., Phillips, J. P., and Boulianne, G. L. (1998). Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat Genet 19, 171-174. Perry, M. E., Mendrysa, S. M., Saucedo, L. J., Tannous, P., and Holubar, M. (2000). p76(HDM2) inhibits the ability of p90(HDM2) to destabilize p53. J Biol Chem 275, 5733-5738. Rao, R. K., and Clayton, L. W. (2002). Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem Biophys Res Commun 293, 610-616. Riemenschneider, M. J., Buschges, R., Wolter, M., Reifenberger, J., Bostrom, J., Kraus, J. A., Schiegel, U., and Reifenberger, G. (1999). Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or HDM2 amplification. Cancer Res 59, 609 1-6096. Roninson, I. B. (2003). Tumor cell senescence in cancer treatment. Cancer Res 63, 2705-2715. Rodriguez, M. S., Dargemont, C., and Hay, R. T. (2001). SUMO- 1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 276, 12654-12659. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J 17, 2596-2606. Saucedo, L. J., Myers, C. D., and Perry, M. E. (1999). Multiple murine double minute gene 2 (HDM2) proteins are induced by ultraviolet light. J Biol Chem 274, 8161-8168. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and pl6INK4a. Cell 88, 593-602. Sheppard, H. M., and Liu, X. (1999). Phosphorylation by DNAPK inhibits the DNA-binding function of p53/T antigen complex in vitro. Anticancer Res 19, 2079-2083. Sherr, C. J., and Weber, J. D. (2000). The ARF/p53 pathway. Curr Opin Genet Dev 10, 94-99. Smith, S., Giriat, I., Schmitt, A., and de Lange, T. (1998). Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 1484- 1487. Sionov, R. V., Moallem, E., Berger, M., Kazaz, A., Gerlitz, O., Ben-Neriah, Y., Oren, M., and Haupt, Y. (1999). c-Abl neutralizes the inhibitory effect of Mdm2 on p53. J Biol Chem 274, 8371-8374. Song, K., Jung, D., Jung, Y., Lee, S. G., and Lee, I. (2000). Interaction of human Ku70 with TRF2. FEBS Lett 481, 81-85. Tanner, K. G, Landry, J., Stemglanz, R., and Denu, J. M. (2000). Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1 -O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A 97, 14178-14182. Tuma, R. (2001). The two faces of oxygen. Sci Aging Knowledge Environ 2001, oa5. Wei, W., Hemmer, R. M., and Sedivy, J. M. (2001). Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol Cell Biol 21, 6748-6757. Xiao, Z. X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., and Livingston, D. M. (1995). Interaction between the retinoblastoma protein and the oncoprotein HDM2. Nature 375, 694-698. Xirodimas, D. P., Chishoim, J., Desterro, J. M., Lane, D. P., and Hay, R. T. (2002). P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett 528, 207-211. Yap, D. B., Hsieh, J. K., Chan, F. S., and Lu, X. (1999). mdm2: a bridge over the two tumour suppressors, p53 and Rb. Oncogene 18, 7681-7689. Yin, Y, Stephen, C. W., Luciani, M. G., and Fahraeus, R. (2002). p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat Cell Biol 4, 462-467. Yogosawa, S., Miyauchi, Y., Honda, R., Tanaka, H., and Yasuda, H. (2003). Mammalian Numb is a target protein of Mdm2, ubiquitin ligase. Biochem Biophys Res Commun 302, 869-872. Zhang, J. (2003). Are poly(ADP-ribosyl)ation by PARP-l and deacetylation by Sir2 linked Bioessays 25, 808-814. Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., and Hung, M. C. (2001). HER-2/neu induces p53 ubiquitination via Akt-mediated HDM2 phosphorylation. Nat Cell Biol 3, 973-982. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/24166 | - |
| dc.description.abstract | 根據細胞所處環境之刺激，可能會有下列三種特殊的樣態呈現在細胞週期進展裡面：細胞生長、細胞死亡以及細胞老化。細胞老化為不可逆且永不再進行細胞複製之現象，因此可與細胞死亡一起作為抑制癌症生長之機制。就如同可以從 p53 dependent 以及 p53 independent 的路徑來誘發細胞死亡，雖可由不同的路徑去誘發細胞老化，但細胞以一整體來反應環境的刺激，因此這些路徑彼此互為交通，最後這些發自細胞質的訊息於核內被整合，而細胞老化亦於該處被執行。
本實驗以 hydrogen peroxide 誘發 WI38 細胞老化，發現以 250μM 的 hydrogen peroxide 會獲得較好的結果，其老化比例為33.9% ；在相同的處理條件下，缺乏 pl6 及 ARF 的 U20S 細胞並無明顯的老化現象。另外，調節細胞週期進展之分子變化方面，p53的量沒有明顯增多，但由 p21 量累積的現象得知 P53 的活性增加； p16 亦逐漸累積，而 pRb 大多是處於低磷酸化的狀態；此外，我們還發現一分子量為 140kDa 的 HDM2 。在 WI38 中，其蛋白質含量隨著誘發後之觀察天數增加而逐漸減少；在 U20S 細胞則無此趨勢，不過與 WI38 相比較，其蛋白質含量卻特別多。以λ－phosphatase 進一步檢視的結果發現該分子為被磷酸化、以sumo－1進行免疫沉澱反應發現其被sumoy－1修飾以及分別以辨識 N 端及 C 端的抗體推測其為 N－terminal truncate 的 HDM2 。此外 ， p140－ HDM2 與pRb有實質交互作用。 細胞老化需要停滯細胞週期進展以及抑制細胞死亡的產生，並且需要 SA heterochromatin foci 的建立，而這些事件都與 pRb 有密切之關聯，既然 P140－HDM2蛋白質含量與老化趨勢相關，且其具有與 pRb 交互作用之能力，因此，或許可以籍此分子一究更深層的細胞老化機制。 | zh_TW |
| dc.description.abstract | Based on the different stimuli, cells could have three major responses. They are cell cycle progression, cell death, and cellular senescence. Cellular senescence is an irreversible and permanent phenomenon of cell cycle arrest. Consequently, cellular senescence as well as apoptosis is recognized as tumor suppressive mechanism. Just like apoptosis induced by p53 dependent and independent pathways, cellular senescence could be elicited from different routes. However, cells react to stimuli coordinately and systematically. Senescent signals from cytosol are integrated in the nucleus and senescence mechanism is executed there. We attempt to induce cellular senescence in WI38 by hydrogen peroxide and find the dose of 250μM to be most effective (33.9%). In contrast, the same treatment could not induce cellular senescence in U20S cells, which lacks p16 and ARF. In addition to morphological phenotype, the amount of p53 is increased slightly. But the increasing activity of p53 is indicated by the accumulation of p21. Besides, the amount of p16 is also accumulated and pRb is hypophosphorylated. Other than 90kDa, we find HDM2 antibody recognized a band of l40kDa size in SDS-PAGE. The p140-HDM2 in WI38 cells decreased day by day after exposure to hydrogen peroxide. Compared with WI38 cells, the protein content of p140-HDM2 was much more plentiful in U20S cells. Revise by λ-Phosphatase, immunoprecipitation with sumo-1 antibody, and immunoblot with anti-N terminal HDM2 antibody suggesting that p140-HDM2 was phophoraylated, sumoylated and N-terminal truncated, respectively. Moreover, it physically interacts with pRb. Cell cycle arrest, inhibition of apoptosis, and construction of SA heterochromatin foci are all required for execution of cellular senescence. Given that p140-HDM2 correlates cellular senescence and could interact with pRb, delving the further mechanism of cellular senescence could be set about from it. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T05:17:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2004 | en |
| dc.description.tableofcontents | 目錄 目錄 . . . . . . . . . . . . . i 圖表目錄. . . . . . . . . . . . . ii 中文摘要. . . . . . . . . . . . . vi 英文摘要. . . . . . . . . . . . . v 引言. . . . . . . . . . . . . 1 壹、細胞老化研究之歷史. . . . . . . . . . . . . 1 貳、老化細胞之形態及其分子層次之定義. . . . . . . . . . . . . 2 參、經由不同路徑促成細胞老化. . . . . . . . . . . . . 3 一、生長路徑的訊息. . . . . . . . . . . . . 3 二、端節喪失功能的訊息. . . . . . . . . . . . . 4 三、去氧核糖核酸損傷及修復系統的訊息. . . . . . . . . . . . . 5 四、 ROS 及粒腺體的訊息. . . . . . . . . . . . . 6 肆、抑癌因數控制迴路. . . . . . . . . . . . . 8 一、在基因層次方面. . . . . . . . . . . . . 10 二、在蛋白質層次方面. . . . . . . . . . . . . 11 三、 HDM2之上游調控者. . . . . . . . . . . . . 11 四、下游被調節者. . . . . . . . . . . . . 12 伍、實驗目的. . . . . . . . . . . . . 13 材料與方法. . . . . . . . . . . . . 16 壹、 細胞培養及 hydrogen peroxide 處理. . . . . . . . . . . . . 16 貳、 senescence associated β－galatosidase stain . . . . . . . . . .17 參、細胞內涵物萃取. . . . . . . . . . . . . 17 肆、 SDS－PAGE 以及西方轉漬法. . . . . . . . . . . . . 18 伍、去磷酸化反應. . . . . . . . . . . . . 19 陸、免疫沉澱反應. . . . . . . . . . . . . 20 柒、membrane stripping. . . . . . . . . . . . . 20 結果. . . . . . . . . . . . . 22 壹、 hydrogen peroxide 誘發細胞老化之形態觀察. . . . . . . . . . . . . 22 一、不同濃度之比較. . . . . . . . . . . . . 22 二、誘發後觀察天數不同之比較. . . . . . . . . . . . . 22 三、 WI38 與 U20S 細胞之比較. . . . . . . . . . . . . 23 貳、調節細胞週期相關因數之生化調查. . . . . . . . . . . . . 23 ?、HDM2之變化及其修飾情形. . . . . . . . . . . . . 24 討論 壹、以 hydrogen peroxide 誘發細胞老化之模式. . . . . . . . 41 貳、WI38 細胞與 U20S 細胞在老化機制的誘發之差. . . . . . . . . 42 參、即HDM2在老化機制上可能之角色. . . . . . . . . . . . 43 一、釐清不同分子量之 HDM2的轉譯後修飾. . . . . . . . . . . . 43 二、 p90－HDM2及 p140－HDM2 與老化機制之關係. . . . . . .46 引用文獻. . . . . . . . . . . . 50 | |
| dc.language.iso | zh-TW | |
| dc.title | 以過氧化氫誘發細胞老化之分子機制 | zh_TW |
| dc.title | Molecular mechanism of cellular senescence by hydrogen peroxide | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | #VALUE! | |
| dc.subject.keyword | NULL | en |
| dc.relation.page | 67 | |
| dc.rights.note | 未授權 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 分子與細胞生物學研究所 | zh_TW |
| 顯示於系所單位： | 分子與細胞生物學研究所 | |
文件中的檔案：
沒有與此文件相關的檔案。
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。